AnaptysBio, Inc. (ANAB)

48.48 +0.25 (+0.52%) USD  |  NASDAQ  |  Dec 31, 16:00
48.00 -0.48 (-0.99%) Pre-Market: 08:36
More

AnaptysBio Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade